833TiPPhase III (COSMIC-312) study of cabozantinib (C) in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

833TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy

Rimassa, L, Cheng, A-L, Braiteh, F, Chaudhry, A, Benzaghou, F, Thuluvath, P, Hazra, S, Borgman-Hagey, A E, Tan, B, Kayali, Z K, Zhu, A X, Kelley, R K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.159
Date:
October, 2019
File:
PDF, 84 KB
2019
Conversion to is in progress
Conversion to is failed